PMID: 3761107Sep 1, 1986Paper

Growth, biochemical status, and mineral metabolism in very-low-birth-weight infants receiving fortified preterm human milk

Journal of Pediatric Gastroenterology and Nutrition
H D ModanlouV Sickles

Abstract

We compared the growth, biochemical status, and mineral status of 30 very-low-birth-weight infants randomly assigned to receive preterm human milk (Group I, 10 infants) from their own mothers, fortified preterm human milk (Group II, 8 infants), or a high-caloric-density premature formula (Group III, 12 infants). Added to the infant's own mother's milk, a human milk fortifier at full strength provided additional protein (60:40 whey/casein, 0.7 g/dl), calories (4 kcal/oz), and minerals. Volume of intake, feeding tolerance, and complications were similar in the three groups. Infants receiving fortified preterm human milk showed growth, biochemical status, and mineral status similar to those receiving high-caloric-density formula, but infants receiving fortified preterm human milk grew faster (12.0 +/- 3.2 vs. 8.9 +/- 1.1 days/300 g, p less than 0.05), had higher serum protein (4.6 +/- 0.5 vs. 4.2 +/- 0.2 g/dl, p less than 0.05), and tended to have better mineral status (higher serum calcium, lower alkaline phosphatase, and higher serum phosphorus, none individually significant) than infants receiving preterm human milk alone. This study supports previous observations that fortified preterm human milk provides nutritional advantage...Continue Reading

Citations

Mar 19, 1988·Lancet
May 21, 1988·Lancet·P RauppO Tönz
Feb 24, 1999·Pediatric Neurology·R D Sheth
Aug 16, 2003·Journal of Paediatrics and Child Health·M J Sharp, K Simmer
Apr 25, 2000·Journal of Pediatric Gastroenterology and Nutrition·G J MoodyR J Shulman
Sep 1, 1994·Acta Paediatrica. Supplement·P Guerrini
Feb 1, 1996·Acta Paediatrica·N J BishopA Lucas
Jan 1, 1996·Archives of Disease in Childhood. Fetal and Neonatal Edition·R J McClure, S J Newell
Oct 21, 2000·Archives of Disease in Childhood. Fetal and Neonatal Edition·R J Cooke, N D Embleton
Jan 7, 2000·Pediatric Research·J FaerkK F Michaelsen
May 8, 2001·Pediatric Clinics of North America·R T Hall
Jul 1, 1988·The Journal of Pediatrics·G M ChanJ W Hansen
Feb 26, 2000·Clinics in Perinatology·S A Atkinson
Mar 6, 2013·The Journal of Pediatrics·David I Tudehope
Feb 19, 2013·Clinics in Perinatology·Manimaran Ramani, Namasivayam Ambalavanan
Sep 21, 2013·Pediatrics and Neonatology·Bai-Horng Su
Apr 1, 1988·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·R J Merritt, S Hack
Dec 30, 2017·Journal of Neonatal-perinatal Medicine·Shabnam LainwalaElizabeth A Brownell
Jun 23, 2018·The Cochrane Database of Systematic Reviews·Emma A AmissahJane E Harding
May 5, 2000·The Cochrane Database of Systematic Reviews·C A Kuschel, J E Harding
Aug 1, 1989·Acta Paediatrica Japonica; Overseas Edition·D P Davies
Feb 1, 1989·Acta Paediatrica Japonica; Overseas Edition·H TsukaharaK Nakamura
Aug 30, 2013·Annals of Nutrition & Metabolism·Jatinder Bhatia
Oct 1, 1991·Journal of the American College of Nutrition·W W Koo, R C Tsang
Dec 9, 2004·The American Journal of Clinical Nutrition·Alexandre LapillonneOlivier Claris
May 9, 2016·The Cochrane Database of Systematic Reviews·Jennifer V E BrownWilliam McGuire
Aug 1, 1988·Nutrition Reviews
Sep 24, 2020·The Cochrane Database of Systematic Reviews·Emma A AmissahJane E Harding
Apr 7, 2021·Journal of the Academy of Nutrition and Dietetics·Tanis R FentonLisa Moloney
Jun 3, 2021·NeoReviews·Elizabeth V Schulz, Carol L Wagner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.